文献

J-GLOBAL ID：202202249898349142   整理番号：22A0328842

ブラジルにおけるSARS-CoV-2ガンマ変異体による再感染およびワクチンブレークスルー後の急性COVID-19症候群【JST・京大機械翻訳】

Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil

著者 (30件)： Penetra Stephanie L.S. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  da Silva Michele F.B. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Resende Paola (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Pina-Costa Anielle (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Pina-Costa Anielle (Serra dos Orgaos Education Foundation, Avenida Alberto Torres, 111 - Alto, Teresopolis, RJ, 25964-004, Brazil) ,  Santos Heloisa F.P. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Guaraldo Lusiele (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Calvet Guilherme A. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Ogrzewalska Maria (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Arantes Ighor (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Zukeram Ketiuce (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  de Araujo Mia F. (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Lima Ana Beatriz Machado (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Lopes Renata Serrano (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Lira-Silva Larissa R. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Moraes Isabella V. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Wakimoto Mayumi D. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Fuller Trevon L. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Fuller Trevon L. (University of California, Los Angeles (UCLA), Box 951752, 10833 Le Conte Avenue 22-442 MDCC, Los Angeles, CA, 90095-1752, USA) ,  Gabaglia Claudia Raja (Biomedical Research Institute of Southern California (BRISC), 4263 Oceanside Blvd#106-159, Oceanside, CA, 92056, USA) ,  Espindola Otavio M. (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Bonaldo Myrna C. (Laboratory of Molecular Biology, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ 21040-3608, Brazil) ,  Daniel-Ribeiro Claudio Tadeu (Department of Immunology, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil) ,  Whitworth Jimmy (Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, United Kingdom) ,  Smith Chris (Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, United Kingdom) ,  Nielsen-Saines Karin (University of California, Los Angeles (UCLA), Box 951752, 10833 Le Conte Avenue 22-442 MDCC, Los Angeles, CA, 90095-1752, USA) ,  Pauvolid-Correa Alex (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Pauvolid-Correa Alex (Texas A&M University, 400 Bizzell St, College Station, TX, 778434, USA) ,  Siqueira Marilda M. (Laboratory of Respiratory Viruses and Measles National Influenza Centre (GISRS-WHO) - Americas Regional Reference Lab for Measles and Rubella - Reference Laboratory for COVID-19 (WHO), Oswaldo Cruz Institute, (IOC), Fiocruz. Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608...) ,  Brasil Patricia (Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz) Avenida Brasil 4365 - Manguinhos, Rio de Janeiro, RJ, 21040-3608, Brazil)
資料名： International Journal of Infectious Diseases  (International Journal of Infectious Diseases)
巻： 114  ページ： 58-61  発行年： 2022年 
JST資料番号： W3271A  ISSN： 1201-9712  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： 著者らは,系統B.1.1.33による感染の387日後に,完全にワクチン接種された医療従事者におけるSARS-CoV-2ガンマ変異体に起因する長期COVID-19の症例を記述する。感染は全ゲノム配列決定により確認し,回復血清試料中の中和抗体の検出により裏付けられた。SARS-CoV-2に対するこの医療従事者の永久曝露を考慮すると,最初の感染後のwaning免疫,COVID-19の防止における不活化ワクチンの低有効性,ガンマ変異体(VOC)の免疫回避,およびCOVID後症候群の負荷,この個体は,異種ワクチンの付加的用量から利益を得た。Copyright 2022 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 血清 ,  *突然変異体 ,  免疫 ,  免疫反応 ,  *ワクチン ,  ブラジル連邦共和国 ,  医療従事者 ,  予防接種 ,  有効性 ,  中和抗体 ,  不活化ワクチン
準シソーラス用語： *重症急性呼吸器症候群 ,  *再感染 ,  ゲノム配列 ,  免疫回避 ,  急性期 , 【Automatic Indexing@JST】

著者キーワード (6件)： SARS-CoV-2変異体 ,  全ゲノム配列決定 ,  再感染 ,  急性期のCOVID-19症候群 ,  COVID-19ブレークスルー感染 ,  医療従事者

分類 (2件)： 免疫療法薬・血液製剤の基礎研究  (GW22010D) ,  感染症・寄生虫症一般  (GD01010H)

タイトルに関連する用語 (8件)： ブラジル ,  SARS-CoV-2 ,  変異体 ,  再感染 ,  ワクチン ,  ブレークスルー ,  COVID-19 ,  症候群